Education
About Us
Working with TipRanks
Follow Us
Dharani Sugars & Chemicals Ltd. (IN:DHARSUGAR)
:DHARSUGAR
Top Page
Dharani Sugars & Chemicals Ltd.
(DHARSUGAR)
Select Model
Select Model
Rating:46Neutral
Price Target:―
The score is primarily driven down by very weak and volatile financial performance—large losses, collapsing revenue, and a highly leveraged balance sheet with negative equity. With no usable technical or valuation inputs provided, these factors are neutral and do not materially offset the financial risk.
Dharani Sugars & Chemicals Ltd. (DHARSUGAR) vs. iShares MSCI India ETF (INDA)
Market Cap
₹286.52M
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)N/A
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees763
SectorConsumer Defensive
Sector Strength42
IndustryFood Confectioners
Share Statistics
EPS (TTM)-4.76
Shares Outstanding33,200,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.19
Price to Sales (P/S)44.14
P/FCF Ratio5.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Dharani Sugars & Chemicals Ltd. Business Overview & Revenue Model
Company DescriptionDharani Sugars and Chemicals Limited engages in the manufacture and sale of white sugar in India. The company is also involved in the generation of electricity; and production of industrial alcohol, including ethanol. In addition, it produces molasses and other by-products. The company was incorporated in 1987 and is based in Chennai, India.
How the Company Makes Money
Dharani Sugars & Chemicals Ltd. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.41M | 7.15M | 0.00 | 8.21M | 396.73M | 310.88M |
| Gross Profit | -60.97M | -429.97M | -7.31M | 1.06M | 48.00M | 46.56M |
| EBITDA | 144.14M | -208.98M | 95.97M | -90.98M | -168.14M | -125.31M |
| Net Income | -354.10M | -929.95M | 1.21B | -313.57M | -401.97M | -380.38M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 4.71B | 4.92B | 5.17B | 5.36B | 5.68B |
| Cash, Cash Equivalents and Short-Term Investments | 6.02M | 3.12M | 4.23M | 6.53M | 1.47M | 58.01M |
| Total Debt | 0.00 | 4.36B | 4.19B | 5.39B | 5.33B | 5.36B |
| Total Liabilities | 1.15B | 6.34B | 5.68B | 7.15B | 7.02B | 6.94B |
| Stockholders Equity | -1.15B | -1.63B | -757.75M | -1.97B | -1.66B | -1.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 59.80M | 1.26B | -54.59M | -29.02M | -135.11M |
| Operating Cash Flow | 0.00 | 60.31M | 1.26B | -54.59M | -29.02M | -135.11M |
| Investing Cash Flow | 0.00 | 214.00K | 1.39M | 895.00K | 423.00K | 6.32M |
| Financing Cash Flow | 0.00 | -62.69M | -1.27B | 58.75M | -27.94M | 180.90M |
Dharani Sugars & Chemicals Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹22.86B | 6.89 | ― | 2.00% | 17.71% | 18.17% | |
66 Neutral | ₹1.82B | 4.93 | ― | ― | 8.83% | 160.77% | |
66 Neutral | ₹16.99B | 18.25 | ― | 0.21% | 16.02% | 48.63% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | ₹22.10B | -12.89 | ― | ― | -11.72% | -439.12% | |
46 Neutral | ₹286.52M | ― | ― | ― | ― | ― |
* Consumer Defensive Sector Average
IN:DHARSUGAR
Dharani Sugars & Chemicals Ltd.
―
―
―
IN:ASALCBR
Associated Alcohols & Breweries Ltd.
867.75
-218.65
-20.13%
IN:BAJAJHIND
Bajaj Hindusthan Sugar Limited
17.21
-10.69
-38.32%
IN:DALMIASUG
Dalmia Bharat Sugar & Industries Ltd.
279.00
-57.27
-17.03%
IN:RANASUG
Rana Sugars Limited
11.98
-5.01
-29.49%
IN:SIMBHALS
Simbhaoli Sugars Ltd
10.00
-7.56
-43.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.